ACRO Names Chair-Elect
The Association of Clinical Research Organizations (ACRO) recently announced the election of Dr. Derek Winstanly as Chair-Elect of the association.
Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
WASHINGTON, July 10 /PRNewswire-USNewswire/ –- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, recently announced the election of Dr. Derek Winstanly as Chair-Elect of the association.
Derek Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, was appointed the 2008 Chair-Elect in June. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.
“I congratulate Dr. Winstanly on his appointment as Chair-Elect of ACRO,” said David Spaight, ACRO Chair and President of MDS Pharma Services. “His experience and insight will enhance the association’s efforts to demonstrate the important contributions that CROs make to the clinical research enterprise.”
“I am pleased to join the leadership of ACRO at a time of extraordinary growth for our industry,” added Dr. Winstanly. “I look forward to driving the association’s efforts to increase public understanding about the vital role CROs play in the conduct of safe and high-quality clinical studies to accelerate the development of new medical treatments.”
About ACRO
The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information, please visit www.acrohealth.org <http://www.acrohealth.org/> .
CONTACT: Courtney Gray Haupt of Association of Clinical Research Organizations, +1-202 543 4018, [email protected]
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Ponsegromab Significantly Improves Body Weight in Patients with Cancer Cachexia
September 17th 2024Results of a Phase II study of ponsegromab showed significant improvements in body weight, muscle function, and overall symptoms for patients with cancer cachexia, offering hope for a new targeted treatment.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
